News Releases Year None20242023202220212020201920182017 NuCana to Participate in Citi's 2018 Global Healthcare Conference Nov 28, 2018 NuCana Reports Third Quarter 2018 Financial Results and Provides Business Update Nov 27, 2018 NuCana to Participate in the 2018 Evercore ISI HealthCONx Conference Nov 20, 2018 NuCana to Participate in the Jefferies 2018 London Healthcare Conference Nov 07, 2018 NuCana Announces First Patients Enrolled in Phase Ib Study of NUC-3373 in Advanced Colorectal Cancer Nov 01, 2018 NuCana Presents Data from Phase I Study of NUC-3373 at ESMO 2018 Oct 22, 2018 NuCana Reports Additional Promising Clinical Data on NUC-1031 (Acelarin®) as Front-Line Treatment of Advanced Biliary Tract Cancer at ESMO 2018 Oct 21, 2018 NuCana to Present New Data from its ProTide Portfolio at the European Society for Medical Oncology (ESMO) 2018 Congress Oct 09, 2018 NuCana to Participate in Citi’s 13th Annual Biotech Conference Aug 29, 2018 NuCana Reports Second Quarter 2018 Financial Results and Provides Business Update Aug 28, 2018 Pagination First page « first Previous page ‹ previous … Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Next page next › Last page last »
NuCana Announces First Patients Enrolled in Phase Ib Study of NUC-3373 in Advanced Colorectal Cancer Nov 01, 2018
NuCana Reports Additional Promising Clinical Data on NUC-1031 (Acelarin®) as Front-Line Treatment of Advanced Biliary Tract Cancer at ESMO 2018 Oct 21, 2018
NuCana to Present New Data from its ProTide Portfolio at the European Society for Medical Oncology (ESMO) 2018 Congress Oct 09, 2018